Stardevson Pharmaceuticals (OPC) Private Limited
About Stardevson Pharmaceuticals (OPC) Private Limited
Data last updated:
Stardevson Pharmaceuticals (OPC) Private Limited is a one person company based in Bilaspur, Chhattisgarh, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 16 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U33309CT2016OPC007473. Its GSTIN is 22AAXCS8079H1ZM (Chhattisgarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Prity Kashyap.
Its last annual general meeting (AGM) was held on 27 August 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Al – 111 Phase – 2 Aasma City Homes Sakri, Bilaspur, Chhattisgarh, India – 495001.
As per the financials filed for FY 2025, the company reported a revenue of ₹74.47 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹1.02 Lakh (net margin 1.4%) and EBITDA of ₹1.02 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Stardevson Pharmaceuticals (OPC) Private Limited's registered office is in Bilaspur, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAl – 111 Phase – 2 Aasma City Homes Sakri, Bilaspur, Chhattisgarh, India – 495001
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
To see the full contact details of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stardevson Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
Financials of Stardevson Pharmaceuticals (OPC) Private Limited
FY 2025 filings availableStardevson Pharmaceuticals (OPC) Private Limited reported revenue of ₹74.47 Lakh (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 60% over three years, including 15% growth in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
Board of directors of Stardevson Pharmaceuticals (OPC) Private Limited
Stardevson Pharmaceuticals has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prity Kashyap | Director | 16 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Stardevson Pharmaceuticals (OPC) Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Teya Pharmaceuticals Private Limited | ₹74.81 Lakh (FY 2019) | Shirpur, Maharashtra, India | ||||
| Nispero Pharmaceuticals Private Limited | ₹74.8 Lakh (FY 2025) | 31.0% | Lucknow, Uttar Pradesh, India | |||
| Morris Pharmaceuticals Private Limited | ₹74.58 Lakh (FY 2024) | 20.0% | Varanasi, Uttar Pradesh, India | |||
| Rbco Pharmaceuticals Private Limited | ₹74.57 Lakh (FY 2024) | 88.0% | Raipur, Chhattisgarh, India | |||
| Stardevson Pharmaceuticals (OPC) Private Limitedthis company | ₹74.47 Lakh (FY 2025) | ₹1.02 Lakh | 1.4% | 15.0% | Bilaspur, Chhattisgarh, India | |
| Aprikose Pharmaceuticals Private Limited | ₹74.18 Lakh (FY 2019) | 32.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
Auditor
Stardevson Pharmaceuticals (OPC) Private Limited is audited by SHEKHAR REDDY AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHEKHAR REDDY AND COMPANY | FY 2017 | 018987C |
Shareholding
The shareholding of Stardevson Pharmaceuticals (OPC) Private Limited is on record for FY 2017, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public |
To see the full shareholding pattern of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 May 2024 | 100957659 | Others | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Stardevson Pharmaceuticals (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stardevson Pharmaceuticals (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stardevson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAXCS8079H1ZM | Chhattisgarh | Active | 23 Mar 2018 |
To see the full GST registrations and return filing status of Stardevson Pharmaceuticals (OPC) Private Limited, buy the company report.
Recent activity
Stardevson Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2016: 1 appointment. The latest: Prity Kashyap was appointed as Director on 16 Aug 2016.
Frequently asked questions
Stardevson Pharmaceuticals is an active company based in Bilaspur, Chhattisgarh, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 16 August 2016 (10+ years old) and is registered under CIN U33309CT2016OPC007473.
Stardevson Pharmaceuticals has 1 current director:
- Prity Kashyap - Director
The latest financial statements of Stardevson Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 August 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Stardevson Pharmaceuticals is 22AAXCS8079H1ZM, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Stardevson Pharmaceuticals is U33309CT2016OPC007473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stardevson Pharmaceuticals was incorporated on 16 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Stardevson Pharmaceuticals by revenue are Teya Pharmaceuticals Private Limited, Nispero Pharmaceuticals Private Limited, Morris Pharmaceuticals Private Limited, Rbco Pharmaceuticals Private Limited, Aprikose Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prity Kashyap was appointed as Director on 16 Aug 2016.
The registered office of Stardevson Pharmaceuticals is at Al – 111 Phase – 2 Aasma City Homes Sakri, Bilaspur, Chhattisgarh, India – 495001.
Stardevson Pharmaceuticals operates in the jewelry and fashion accessories industry, in the manufacturing segment.
Stardevson Pharmaceuticals has open charges of ₹9.5 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
